Keyword: Biologics License Application (BLA)
News
16.07.2024
-
CordenPharma announced its largest strategic investment to date, committing to spend ~€900m over the next three years to enhance its peptide technology platform.
News
29.01.2016
- The US Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) submitted by UK-Swedish drugmaker AstraZeneca in partnership with Canadian...
News
13.02.2015
- Swiss fine and specialty chemicals producer Lonza has signed a toll manufacturing agreement with TiGenix, an advanced biopharmaceutical company focused on developing and...
